Autism Spectrum Disorder Trial, Recruiting NCT06495684 Sponsor: University of New Mexico Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06495684
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 35 years old
  • You are able to read and communicate proficiently in English
  • You have a formal diagnosis of autism or autism spectrum disorder, OR you score 17 or higher on a specific autism questionnaire called the Autism Quotient (AQ)
  • You have good vision and hearing, or these are corrected to a good level (for example, with glasses or hearing aids)
  • You are right-handed, as confirmed by a standard handedness questionnaire
  • You score 85 or higher on a thinking and reasoning assessment called the Shipley-2 (confirm with trial site)

Who may not be able to join:

  • You have ever lost consciousness for more than 5 minutes
  • Any of your immediate biological family members (such as a parent or sibling) have a history of epilepsy or seizures
  • You have a significant ongoing medical condition, such as a neurological disorder or a long-term illness
  • You have any surgically implanted metal anywhere above your neck (for example, metal pins, plates, cochlear implants, aneurysm clips, or brain electrodes)
  • You have been hospitalised for depression, anxiety, or substance abuse within the past 12 months
  • You are currently pregnant
  • You have a pacemaker
  • You have a history of any neurological condition such as stroke, multiple sclerosis, bipolar disorder, encephalitis, epilepsy, seizures, or ALS (amyotrophic lateral sclerosis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bill Shuttleworth, Ph.D., University of New Mexico

Phone: 575-646-4313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of New Mexico
Registry
ClinicalTrials.gov
Start date
12 March 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measure of Emotional Distress - Anxiety; Measure of Social Anxiety; Measure of Social Anxiety/Anxiety; Measure of Social Anxiety; Measure of Social Impairment; Measure of Empathy; Measure of Prosodic Alignment; Measure of Emotion Expression Entrainment; Measure of Social Learning; Measure of Quality of Life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov